News Prime minister accused of being "in denial" about NHS crisis PM under fire over A&E waiting times.
News Does Jeremy Corbyn want to nationalise the pharma industry? Labour leader criticises rival's previous role
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
